Business Context and Reporting Period
This Form 8-K was filed by TenX Keane Acquisition (referred to in metadata as Citius Oncology, Inc.) on July 18, 2023. The registrant is a Cayman Islands-based special purpose acquisition company (SPAC) listed on The Nasdaq Stock Market LLC under the symbols TENKU, TENK, and TENKR. The filing reports on the extension of the deadline to complete its initial business combination.
Key Financial Metrics
The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, or margins, as the company is in the pre-business combination phase. The specific financial details disclosed are:
- Extension Fee: $660,000 deposited into the trust account.
- Debt Obligation: An unsecured promissory note issued to the Sponsor (10XYZ Holdings LP) in the principal amount of $660,000.
- Interest Rate: 0% (non-interest bearing).
- Conversion Option: The Sponsor may convert the note, in whole or in part, up to $1,500,000 into private units at $10.00 per unit.
Material Changes
The primary material change is the extension of the timeline to consummate a business combination. The deadline has been extended by three months from July 18, 2023, to October 18, 2023. This extension was facilitated by the deposit of the $660,000 Extension Fee into the trust account, evidenced by the issuance of the Promissory Note.
Outlook, Risks, and Contingencies
Management Commentary: The company has utilized one of its three available extension options. The Promissory Note is payable in full upon the consummation of the business combination (Maturity Date).
Risks and Contingencies: The Promissory Note includes specific events of default, including failure to pay within five business days of the Maturity Date, bankruptcy proceedings, breach of obligations, cross defaults, enforcement proceedings, or unlawfulness. In the event of default, the note may be accelerated.
Unusual Items: The issuance of the Promissory Note was made pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
Investor Verification Checklist
- Verify the current status of the trust account and the total funds available for redemption or business combination.
- Confirm whether the Sponsor has elected to convert the $660,000 promissory note into private units.
- Monitor the company's progress toward identifying and closing a target business combination by the new deadline of October 18, 2023.
- Review the attached Promissory Note (Exhibit 10.1) for full legal terms regarding default and acceleration.